SCHEMBL1957579

SCHEMBL1957579

COc1ccc(/C(C#N)=C/c2ccc(N3CCCCC3)o2)cc1OC

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 16/20 0.65
MEN1 O00255 15/20 0.65
KMT2A Q03164 15/20 0.65
ALDH1A1 P00352 12/20 0.65
NPSR1 Q6W5P4 9/20 0.65
PKM P14618 8/20 0.65
HPGD P15428 8/20 0.65
RAB9A P51151 8/20 0.65
TDP1 Q9NUW8 7/20 0.65
ALOX12 P18054 4/20 0.65
RECQL P46063 4/20 0.65
HSP90AA1 P07900 1/20 0.65
CACNA1B Q00975 1/20 0.65
APBA1 Q02410 1/20 0.65
S1PR2 O95136 1/20 0.65
TP53 P04637 1/20 0.65
ALOX15 P16050 1/20 0.65
MAPK1 P28482 1/20 0.65
HBB P68871 1/20 0.65
HSD17B10 Q99714 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1957583 1.00 MAPT (0.65) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL1957931 0.90 MAPT (0.54) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL1959899 0.90 MAPT (0.69) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL1959900 0.90 MAPT (0.69) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL1957933 0.90 MAPT (0.54) MAPTMEN1KMT2AALDH1A1NPSR1
Hydrochloric Acid SCHEMBL4523065 0.89 MAPT (0.53) MAPTMEN1KMT2AALDH1A1NPSR1
Hydrochloric Acid SCHEMBL4523074 0.89 MAPT (0.53) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL1959559 0.89 ABCB1 (0.64) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL1959558 0.89 ABCB1 (0.64) MAPTMEN1KMT2AALDH1A1NPSR1
SCHEMBL1959077 0.86 MAPT (0.50) MAPTMEN1KMT2AALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2332905-B1 BCRP/ABCG2 Inhibitor YAKULT HONSHA KK (JP) 2017-03-01 EP claimed
US-8697742-B2 BCRP/ABCG2 inhibitor KABUSHIKI KAISHA YAKULT HONSHA (JP) 2014-04-15 US claimed
EP-2332905-A1 BCRP/ABCG3 Inhibitor Kabushiki Kaisha Yakult Honsha (JP) 2011-06-15 EP claimed
US-20090253656-A1 BCRP/ABCG2 INHIBITOR KABUSHIKI KAISHA YAKULT HONSHA (JP) 2009-10-08 US claimed
EP-1864972-A1 BCRP/ABCG2 INHIBITOR Kabushiki Kaisha Yakult Honsha (JP) 2007-12-12 EP claimed
EP-2332905-B1 BCRP/ABCG2 Inhibitor YAKULT HONSHA KK (JP) 2017-03-01 EP disclosed
US-8697742-B2 BCRP/ABCG2 inhibitor KABUSHIKI KAISHA YAKULT HONSHA (JP) 2014-04-15 US disclosed
EP-2332905-A1 BCRP/ABCG3 Inhibitor Kabushiki Kaisha Yakult Honsha (JP) 2011-06-15 EP disclosed
US-20090253656-A1 BCRP/ABCG2 INHIBITOR KABUSHIKI KAISHA YAKULT HONSHA (JP) 2009-10-08 US disclosed
EP-1864972-A1 BCRP/ABCG2 INHIBITOR Kabushiki Kaisha Yakult Honsha (JP) 2007-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253656-A1 BCRP/ABCG2 INHIBITOR ABCC1, ABCB1, BRCA1 MAPT 3660/4885MEN1 4169/4885KMT2A 1946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.